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Abstract Estimation of regional tissue oxygenation
(rStO2) by near infrared spectroscopy enables non-invasive
end-organ oxygen balance monitoring and could be a
valuable tool in intensive care. However, the diverse
absolute values and dynamics of different devices, and
overall poor repeatability of measurements are a problem.
The aim of the present study is to test the hypothesis that
INVOS 5100C, FORE-SIGHT and NONIN EQUANOX
7600 have similar properties concerning absolute values,
repeatability, and sensitivity to changes in rStO2. To test
repeatability the sensors were repositioned 20 times during
hemodynamic steady state on the adult forearm. After-
wards six vascular occlusions by inflation of an upper arm
cuff were done to achieve low oxygenation in the forearm.
Absolute values were compared by repeated-measures
ANOVA, repeatability was estimated by the within-subject
standard deviation, Sw, and response to changing oxygen-
ation by the down slope of rStO2 during vascular occlusion
in the respective arm. 10 healthy adults, 21–29 years old,
with double skinfolds on the forearm less than 10 mm
participated. The median rStO2 was 70.7 % (interquartile
range (IQR) 7.7 %), 68.4 % (IQR 8.4 %), and 64.6 % (IQR
4.8) with INVOS, NONIN, and FORE-SIGHT, respec-
tively, the median rate of decline was 13.2 %/min (IQR
9.6), 22.8 %/min (IQR 18.0), and 10.8 %/min (IQR 6.0),
and the same-site repeatability was 2.9 % (95 % CI
2.4–3.3), 4.6 % (CI 3.9–5.3), and 2.0 % (CI 1.7–2.3). IN-
VOS gave significantly higher steady state values than
FORE-SIGHT, and NONIN had the steepest decline in
rStO2, but the poorest repeatability. Two measures of
signal-to-noise were similar among devices. This suggests
that good repeatability comes at the expense of low sen-
sitivity to changes in oxygenation. Values of rStO2 on the
forearm from INVOS, NONIN and FORE-SIGTH cannot
be used interchangeably.
Keywords Near infrared spectroscopy (NIRS) 
Oxygenation  Muscle  Medical device
1 Introduction
Near infrared spectroscopy (NIRS) enables estimation of
the regional tissue haemoglobin oxygen saturation (rStO2).
rStO2 is a weighted average of the saturation in arterial and
venous blood in the illuminated tissue. The arterial-to-
venous ratio is about 25:75 and rStO2 is therefore closer
correlated to the venous than to the arterial saturation [1].
Thus NIRS is a non-invasive, continuous estimate of the
regional oxygen delivery-consumption balance and could
potentially detect low regional blood flow that would
otherwise go undetected [2]. However implementation into
standard clinical care has yet to be seen. This is likely due
to lack of convincing outcome data and randomized trials
in combination with rather costly equipment. Furthermore
previous studies have shown that a repeated measurement
can vary up to 14 percentage points (95 % CI) [3–5]. This
large intra-subject variability is an issue that needs
improvement, before the potential of the technology can be
fully realized.
Near infrared spectroscopy oximetry is based on the fact
that hemoglobin exist in two main forms, oxyhemoglobin
(O2Hb) and deoxyhemoglobin (HHb), each having its own
particular optical absorption characteristics. Most com-
mercial devices apply continuous wave spectroscopy and
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use a multi-distance approach measuring the reflected light
attenuation at several wavelengths as a function of distance
from the light source. Assumptions regarding the wave-
length dependence of scattering is necessary to derive the
spectral shape of absorption coefficient and thereby deduce
rStO2 [6]. These assumptions in combination with
assumptions about the water content and the different light
emitter and detector geometry probably account for the
differences between devices.
It is well established that peripheral muscle rStO2 is a
hemodynamic variable, that at least on group level dif-
fers between the healthy and the severely ill [7, 8], and
is related to clinical relevant outcomes [7, 9, 10]. While
these studies were done with different NIRS oximeters
on different sites on the body the issue of generaliz-
ability is a hindrance to widespread clinical implemen-
tation. A recent review by Scheeren et al. [11] addresses
some of the current strengths and limitations of the
technology.
The new generation of NIRS sensors are FDA approved
to claim reliable absolute values meaning that clinical val-
idation studies have shown sufficient precision compared to
a weighted average of arterial and jugular bulb saturation
[12]. This should translate into better repeatability of
measurements and suggests a significant step forward for
the technology. Previous studies comparing different NIRS
devices focus primarily on steady state comparison of mean
values, whereas no estimates are given for repeatability or
sensitivity to changing oxygenation. When comparing dif-
ferent devices all three parameters are of importance: the
absolute rStO2 values during the normal state, the changes
in rStO2 when oxygenation is altered, and the repeatability,
i.e. the similarity of repeated measurements.
The aim of the present study is test the hypothesis that
three commercial NIRS devices for peripheral measure-
ments have similar absolute values of rStO2. Secondary
outcomes include repeatability of measurements and slopes
of changes in rStO2 during a vascular occlusion test. The
devices compared are INVOS 5100cTM (Covidien, Boulder,
CO, USA), a trend monitor, FORE-SIGHTTM (CAS Medical
Systems Inc, Branford, CT, USA), and NONIN EQUANOX
7600TM (Nonin Medical Inc, Plymouth, MN, USA) that both
are FDA approved for absolute measurements.
2 Materials and methods
This study was approved by the local Ethics Committee
(Journal no. H-3-2012-004) and conducted at the national
university hospital, Rigshospitalet, Denmark. Written
informed consent was obtained from the participants before
inclusion. The study was registered at clinicaltrials.gov (ID
NCT01552785).
Recruitment of healthy volunteers was accomplished by
an ad in a local university paper. Inclusion criteria included
normal health and a skinfold thickness of less than 10 mm
on the lower arm measured by the Harpeden caliper to
minimise the contribution of subcutaneous tissue. Exclu-
sion criteria were pregnancy, hypertension, peripheral
vascular disease, and local skin disease.
All measurements were done with subjects placed in
upright position with the lower arm at heart level. The
outline of each sensor was marked by a pen on the upper
part of the flexor muscles of the lower arm to ensure that
the sensors were applied to the same spot each time.
2.1 Absolute values and repeatability
The absolute rStO2 values of each device and repeatability
of measurements during hemodynamic steady state were
tested with one device at a time. First 20 seconds (s) of
measurement was repeated 10 times at the marked site with
total sensor lift up between repeats (Area 1 Fig. 1). As
sensor repositioning in the clinical setting is likely to be at
a slightly different site the sequence was repeated with the
sensor being re-positioned at slightly differing sites around
the area (Area 2 Fig. 1). This way an estimate of both the
‘optimal’ and the ‘clinical’ repeatability is achieved. This
gave 2 9 10 steady state measurements with each device
on each participant.
2.2 Sensitivity to changes in oxygenation
Secondly testing of device sensitivity to changing oxy-
genation was done with a vascular occlusion test inflating a
cuff around the upper arm at heart level to more than
250 mmHg. 20 s of baseline rStO2 with each device was
recorded before the cuff was inflated. 10 s after cuff
inflation the different sensors were applied at the same site
(Area 3 Fig. 1) sequentially to obtain three 1-min cycles of
measurement of down-sloping rStO2. Each device mea-
sured 20 s within each cycle. After cuff deflation each
device recorded 10 s of rStO2 during the short steady state
of subsequent hyperperfusion (Fig. 2). The sequence of the
Fig. 1 The areas on the arm used for the measurements. Area 1 is the
marked area for same site repeated measuresments, Area 2 is the area
of repeated measurement at different sites, and Area 3 is the marked
area of sensor position during cuff occlusion
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three devices was changed between occlusions and six
occlusions per subject were done ensuring a balanced
design.
As the adhesive strength of the sensors wears off with
repeated measurements the sensors were held in place by
hand. This was found to be the most reliable way to get
stable measurements, while great care was taken not to
induce pressure on the tissue while avoiding possible
source-to-detector light piping. All sensors were positioned
so that the light path was parallel to the longitudinal
direction of the muscles below. The experiment typically
lasted 180 minutes in total per subject.
2.3 NIRS instruments
The three NIRS devices tested all use the multi-distance
approach.
INVOS 5100cTM with adult SomaSensorTM (SAFB-SM)
uses two LED sources (730 and 810 nm) at one position
and two photodiode detectors at a distance of 3 and 4 cm,
and ‘‘subtracts’’ the short distance signal from the longer
distance in order to diminish the contribution of the skin
and scalp.
NONIN EQUANOXTM 7600 with EQUANOX Advan-
ceTM Sensor, Model 8004CATM uses four LEDs (730, 760,
810, and 880 nm) in each of two positions 6 cm apart with
two photodiode detectors 2 cm apart in between in a
symmetrical design.
FORE-SIGHTTM Cerebral Oximeter with the medium
sensor uses a 4-wavelength (690, 779, 808, and 850 nm)
laser source delivered to the sensor through an optical fibre
and two photodiode detectors 1.25 and 4 cm from the
source, respectively.
We will refer to the measured regional tissue oxygena-
tion as rStO2 irrespective of instrument.
2.4 Statistical analysis
The a priori hypothesis was that the instruments have
similar absolute values.
Sample size was calculated to have a power of 80 % to
detect a 5-percentage points difference between absolute
values with a standard deviation of 5 % and a paired
design. A repeated measures general linear model tested
differences in absolute values between devices with device
as within-subject factor. Residual plots were visually
assessed to assure reasonable fit. If data were either highly
skewed or the variance was heterogeneous among groups a
related samples Friedman test was used. If a significant
device effect was found, post hoc pair-wise comparison
was carried out.
Repeatability for each instrument was determined by
one-way ANOVA with subject as the factor. The within-
subject standard deviation, Sw, was then estimated from the
square root of the residual mean square. The 95 % CI being
±1.96 times Sw/root(2n(m - 1)), where n is number of
subjects and m the number of observations per subject.
To assess the dynamic properties of each device a
simple, least square linear regression was applied to each
20 s sample of rStO2 recording during occlusion based on
the approximation that the decline in rStO2 over time is
linear during the first 3 min of desaturation [13, 14].
Two different approaches to estimate a signal-to-noise
ratio (SNR) for each device were used. For each device on
each subject a SNR was derived from the mean of the first
cycle slopes divided by the same-site within-subject
Fig. 2 Schematic presentation of the measurements during cuff inflation and deflation
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standard deviation (slope-SNR). Secondly data from the
steady-state measurements were used. From a one-way
ANOVA with the 20 s measurement as factor the sponta-
neous within-measurement fluctuations in rStO2 was used
as signal while the between measurements variance was the
noise term (variance-SNR). All data were log-transformed
before the SNR analyses to achieve normal distribution.
Data were tested for normality with the Sharpiro Wilk
test. Results from data with normal distribution are repor-
ted as mean with 95 % CI, whereas all other results are
given as median with interquartile range. A p value below
0.05 was considered significant. Bonferroni adjustment was
applied where appropriate.
All data was analysed in a Matlab versus R2011b (The
MathWorks, Inc, Natick, MA, USA) script. All statistical
tests were done in SPPS statistics version 20 (IBM, Corp,
Armonk, NY, USA).
3 Results
10 subjects (5 male/5 female) healthy adults with an age
range of 21–29 years and a median skinfold of 5.2 mm
(IQR 3 mm) were included.
3.1 Absolute values
During resting steady state the overall median rStO2 was
70.7 % (IQR 7.7 %), 68.4 % (IQR 8.4 %), and 64.6 %
(IQR 4.8) with the INVOS, NONIN, and FORE-SIGHT,
respectively (Table 1; Fig. 3). In pairwise comparison only
INVOS versus FORE-SIGHT were significantly different
(p = 0.01).
During post-cuff-deflation reperfusion the median rStO2
was 85.3 % (IQR 11.3 %) with INVOS, 88.0 % (IQR
14.0 %) with NONIN, and 77.7 % (IQR 10.5 %) with
FORE-SIGHT. The FORE-SIGHT was significantly lower
than the two other devices (p \ 0.0001) in both pair-wise
comparisons.
3.2 Repeatability
The repeatability of FORE-SIGHT was best, while the
repeatability of NONIN was worst (Table 2; Fig. 3). There
was no difference between same-site repeatability and
various-site repeatability.
3.3 Sensitivity to changes in oxygenation
The slopes of desaturation were steepest with NONIN
(p \ 0.0001) in both pair-wise comparisons, while the
slopes of INVOS and FORE-SIGHT were similar
(Table 3). Often both NONIN and INVOS reached their
lower limit of recording before the start of third cycle of
measurement giving an unequal number of observations
per device, thus both analysis of data from all three cycles
and only the first cycle was done giving the same main
results (Fig. 4).
3.4 Signal-to-noise ratio
Both the cuff-induced slope-SNRs and spontaneous vari-
ance-SNRs were similar among devices. Slope-SNRs were
22.0 min-1 (CI 18.8–25.7), 23.8 min-1 (CI 19.7–28.8),
and 22.0 min-1 (CI 17.8–27.1) with INVOS, NONIN, and
FORE-SIGHT, respectively (p = 0.5). The variance-SNRs
were 0.26 (CI 0.19–0.36), 0.24 (CI 0.18–0.32), and 0.21
(CI 0.16–0.26) with INVOS, NONIN, and FORE-SIGHT,
respectively (p = 0.3).
4 Discussion
4.1 Important findings
The median resting steady state absolute values of the three
oximeters were within 6 percentage points, whereas the
values during deoxygenation were markedly different. The
repeatability of FORE-SIGHT was best, while NONIN had
the steepest slope of change during deoxygenation. The
three devices had similar signal-to-noise ratios. Figure 3
illustrates this as the NONIN can be seen to have both the
largest within-subject as well as between-subject variance.
4.2 Appraisal of method
This study was designed to compare three commercial
NIRS oximeters and hypothesized that the devices give
similar readings. The three sensors have quite different
Table 1 The absolute values of rStO2 of each device
Device Position N Median (%) IQR (%)
INVOS Same site 100 70.5 8.0
Various sites 100 71.0 8.5
Total 200 70.7 7.7
NONIN Same site 100 67.0 8.3
Various sites 100 69.5 8.6
Total 200 68.4 8.4
FORE-SIGHT Same site 100 63.8 4.7
Various sites 100 65.8 6.3
Total 200 64.6 4.8
Total Same site 300 66.7 8.5
Various sites 300 68.6 8.5
Total 600 67.7 8.8
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light source and detector geometries and it could be argued
that the volumes of tissue being examined are so different,
that systematic difference are to be expected. However, if
the overall goal is to provide a single, simple measure of
tissue oxygenation for clinical use then similarity among
oximeters is necessary.
The strength of our method is that it both gives an
estimate of repeatability together with a measurement of
the sensitivity to changing oxygenation. The method is
easily reproducible and allows fast comparison of several
instruments in healthy subjects with almost no risk. Vas-
cular occlusion by cuff is a simple and robust way of
inducing maximal tissue deoxygenation, allowing efficient
estimation of device sensitivity. The response to cuff
inflation and subsequent deflation probably varied during
the six runs in each subject, but as our test design with each
devices measuring on every round in a balanced manner, it
is unlikely to have caused bias.
One important limitation of our study is that total
occlusion of blood flow by a manually inflated cuff is not
physiological. It results in a slight increase in blood volume
due to the arterial inflow while the cuff pressure builds up
and the venous outflow is already occluded. Thus the
arterial to venous volume ratio (A:V ratio) is likely to
decrease. In systemic hypoperfusion and sepsis the A:V
ratio probably increases so the translation to clinical
measurements may not be straightforward. Moreover the
adhesive strength of the sensors wears off with repeated
repositionings so the sensors were held by hand. Small
differences in local pressure squeezing blood from super-
ficial vessels cannot be completely excluded, but great care
was taken and it is unlikely to have influenced the mea-
surements much. Lastly it should be noted that these sen-
sors are primarily intended for continuous monitoring
whereas spot measurements are the cornerstone of this
study. There are, however, no physiological or technical
reason to believe that a reliable baseline measurement
cannot be achieve within 10 s of stable readings as the used
NIRS devices do not require calibration procedures or
warm up.
4.3 Comparison with previous studies
Our results compare reasonably well with previous find-
ings. The median baseline values measured in the range of
65–75 % were slightly higher with the INVOS. This is in
accordance with other studies [15–17]. While in our pre-
vious similar study INVOS 5100C with the same adult
sensor had a similar mean rStO2 of 70.2 ± 6.7 % [5]
.
It is interesting that the Sws of all instruments were quite
low, meaning better repeatability than expected. Most















Fig. 3 The results from the
steady-state same-site and
various-site measurements.
INVOS is red, NONIN green,
and FORE-SIGHT blue
(presented in that order from left
to right). Each device-subject
pair has the same-site
measurements to the left and
various-site measurements to
the right. The boxes represents
the interquartile ranges, the
whisker the range, and the
horizontal bar the median.
Outliers are marked by a red
plus symbol
Table 2 The repeatability of same site and various site repositionings
Same site Various sites
Sw (%)
a CI (%)b Sw (%)
a CI (%)b
INVOS 2.9 2.4–3.3 3.6 3.0–4.1
NONIN 4.6 3.9–5.3 3.8 3.3–4.4
FORE-SIGHT 2.0 1.7–2.3 2.4 2.0–2.7
a Sw: the within-subject standard deviation of the 10 repeated
measurements
b CI: 95 % confidence interval









INVOS 13.2 9.6 10.4 8.5
NONIN 22.8 18.0 21.8 18.0
FORE-SIGHT 10.8 6.0 8.5 5.7
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studies have reported repeatability of about 5–6 % [3, 4,
18, 19]. In respect to the INVOS we have no good expla-
nation for the difference in repeatability compared to our
own, previous study, since both methods and subjects were
similar.
To our knowledge these instruments haven’t been tested
and compared on muscle before. Data from the brain
suggest that the FORE-SIGHT has better repeatability than
INVOS [16]. Comparing the three instruments with a ref-
erence rStO2 calculated from jugular bulb and arterial
blood in the human adult the accuracy root mean square
was 4.26 % with FORE-SIGHT, 9.69 % with INVOS, and
6.27 % with NONIN [15]. While the accuracy root mean
square is not straightforwardly comparable to the Sw in the
present study the differences between instruments should
be the same. It is thus again noticeable that INVOS per-
formed better in our study.
The InSpectra Model 325 (Hutchinson Technology Inc.,
Hutchinson, MN, USA) is a NIRS device specifically
designed for peripheral measurements only. Comparing the
slopes of desaturations in %/min of INVOS and FORE-
SIGHT from present study with a study using the InSpectra
on the forearm and thenar muscle shows reasonable
agreement [20].
DrStO2 in a recent study comparing the changes in rStO2
during a circumferential pneumatic head cuff inflation to
estimate the contribution of extra-cranial scalp tissue were
16.6 ± 9.6, 11.8 ± 5.3, and 6.8 ± 6.0 % with INVOS,
FORE-SIGHT, and NONIN, respectively [17]. Interest-
ingly the ratio of DrStO2(INVOS)/DrStO2(FORE-SIGHT) are
similar in our study. This suggests that the differences in
dynamics found on the arm could be similar on the head,
and that the differences in so-called removal of extra-cra-
nial tissue contamination as presented in the study by
Davie and Grocott could be simply a matter of different
sensitivity to overall oxygenation changes in the tissue. The
results with the NONIN are not comparable to present
study as the classic Model 8000CA sensor was used, that
previously has been found to be less sensitive than the new
Model 8004CA [15], which was the sensor used in our
study.
4.4 Clinical relevance
It is a key problem of NIRS tissue oximetry that there is no
reference standard. We did not draw arterial and venous
blood samples, as it is uncertain how well the venous sat-
uration reflects the tissue oxygenation in a state of no flow.
The fact that NONIN and INVOS often reached their lower
boundary values while FORE-SIGHT showed continuing
deoxygenation at a level of 20–30 % suggests that NONIN
and INVOS overestimate true deoxygenation in the adult
human forearm. It is not certain that FORE-SIGHT is
closer to the ‘true’ values, but at least the continued decline
in rStO2 is likely to represent truly changing oxygenation.
It is noticeable that the results suggest that the vari-
ability of repeated measurements is independent of whether
the sensors are repositioned at same site or at a different
site. The implies at least on the lower arm that the exact
sensor position is less important and that the source of
variance is not so much differences in muscle oxygenation
between adjacent tissues, but perhaps more a combination
of physiologic fluctuations and optical heterogeneity on a
smaller scale—such as hair and subcutaneous blood vessels
in the light path.
When NIRS oximetry is used for trend monitoring the
repeatability of measurement is less important, but good
repeatability is paramount if NIRS is to be used as a spot
measurement or if the monitoring is started when the
patient status is uncertain, e.g. on admission to critical care.
Moreover in critical care the sensor has to be repositioned
during prolonged monitoring to avoid skin damage. The
dynamic sensitivity in relation to repeatability is equally
important since it is an estimate of the reliability of
potential hypoxic levels of tissue oxygenation. If, for the
sake of argument, it is assumed that a jugular bulb satu-
ration below 50 % indicates cerebral ischemia, then with a
A:V ratio of 25:75 this theoretically corresponds to rStO2
61 %, if the SaO2 is 95 %, thus with a Sw of 5 % a spot
measurement should be below (61 % - 1.96 9 5 %)
52 % to be more than 95 % certain that the tissue is
actually ischemic and above (61 % ? 1.96 9 5 %) 71 %
to be certain that it is not. If in addition the sensitivity to
changes is low the risk of undetected true hypoxia will be
high. The actual changes in oxygenation induced by cuff
inflation-deflation, is unknown in the current setup, but it is
safe to say that the three tested devices do not agree about
Fig. 4 An example of the first vascular occlusion test on a subject.
The grey dots are INVOS; the black dots are FORE-SIGHT; the blank
dots are NONIN. The continuous tracing is from another occlusion,
but is included to illustrate the typical oxygenation trend. The
horizontal lines represent steady state measurements. The regression
lines are included for each of the 20 s measurements during the
occlusion. Note that NONIN only have two measurements during the
occlusion due to loss of signal
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the magnitude of changes. A pragmatic approach would be
to care less about the closeness to the ‘true’ values, but to
settle for the device with the best combination of repeat-
ability and sensitivity to changing oxygenation. However
our results suggest that high sensitivity comes at the
expense of good repeatability, as our estimates of signal-to-
noise ratios for each device were similar.
The lack of a reference standard is a drawback for the
technology and it would be a large step forward if an
international standard could be determined. One problem
with in vivo testing as done in the present study is that
results may or may not be generalizable to other tissues. It
is thus important to test and compare the commercial
available NIRS equipment on different sites in different
populations. In-vitro phantom testing could also prove
useful, but has not been widely used with commercial
equipment, even though it could perhaps provide a possible
framework for a future standardization procedure.
5 Conclusion
In conclusion we found that INVOS 5100C with the adult
SomaSensor, NONIN EQUANOX 7600 with sensor
8004CA, and FORE-SIGHT with medium sensor all had
pair-wise differences in either median absolute values,
repeatability, and/or dynamic measurements. A standard-
ized testing procedure would be a step forward for the
technology.
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